Anika Therapeutics Delivers Solid Second Quarter 2015 Financial Results and Continued Pipeline Progress

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. ABBV
3. MU
4. ACN
5. IBM
6. META
7. SPY
8. NVDA
9. PRIM
10. PFE

Go back to Anika Therapeutics Delivers Solid Second Quarter 2015 Financial Results and Continued Pipeline Progress

Anika Therapeutics (ANIK) Tops Q2 EPS by 17c

July 29, 2015 4:26 PM EDT

Anika Therapeutics (NASDAQ: ANIK) reported Q2 EPS of $0.51, $0.17 better than the analyst estimate of $0.34. Revenue for the quarter came in at $22.9 million versus the consensus estimate of $21.65 million.

The solid results we delivered in the second quarter demonstrate accelerating demand, which combined with our... More